semaglutide · Novo Nordisk
What should I know about Ozempic?
Ozempic by Novo Nordisk: Type 2 diabetes. Cost, side effects, dosing as labeled, comparisons and the latest news, all sourced.
Start hereOzempic FAQ: The Questions Americans Actually SearchStraight answers to the most-searched Ozempic questions in 2026, covering what it treats, the new Ozempic pill, dosing, cost, insurance, side effects and the lawsuits.
FAQ
Mounjaro: 50 Questions People Ask GoogleThe fifty questions Americans actually type into Google about Mounjaro, answered from the FDA label, Eli Lilly's own pricing pages and the 2026 approvals — including why US and UK answers disagree, what the new heart indication does and does not say, and what a month really costs on every payment route.Semaglutide FAQ: 50 Questions People Ask GooglePlain-English answers to the 50 questions Americans most often type into Google about semaglutide, from what it is and how much it costs to what happens when you stop.
Alternatives
"Nature's Ozempic" Claims: A Fact CheckBerberine, yerba mate, psyllium, apple cider vinegar, Akkermansia and oat water have all been called "nature's Ozempic." We checked each claim against the trial data, the retractions and the regulatory record. Here is what holds up and what does not."Research Peptides" and the Gray Market: What Buyers Need to KnowVials labeled semaglutide, tirzepatide or retatrutide sold "for research purposes only" are the highest-risk option in the weight-loss market. The FDA says they are illegally sold unapproved drugs, and a 2026 analysis of 652 patients found gray-market retatrutide produced less weight loss and more cardiovascular symptoms than the real drug.Berberine vs Ozempic: What the Evidence Actually SaysBerberine has been called "nature's Ozempic" since 2023. It is a real plant compound with real effects on blood sugar and cholesterol, but pooled trial data show it produces somewhere between zero and two pounds of weight loss, compared with roughly 33 pounds for semaglutide in its main trial. Here is the side-by-side.Contrave vs Wegovy: Which Weight Loss Drug Fits Which Person?Contrave is an oral pill aimed at cravings and food reward. Wegovy is a weekly injection that produces roughly three times more weight loss. Contrave can cost as little as $20 a month with a copay card. Here is the full comparison, including the boxed warning most people do not know about.Metformin for Weight Loss vs GLP-1s: How Big Is the Gap?Metformin costs a few dollars a month, has a 60-year safety record, and produced about 2 kg of weight loss in the Diabetes Prevention Program that held for a decade. Semaglutide produced 15 kg in 68 weeks. Here is what metformin is genuinely good at, and where the comparison stops making sense.Phentermine vs GLP-1s: Cost, Results and Who Each One SuitsPhentermine costs about $14 to $41 a month and has been on the market since 1959. Wegovy and Zepbound cost $299 to $449 and produce three to five times more weight loss. Here is the real comparison, including the label limits most articles skip.
How-to guides
At the Pharmacy Counter: Savings Cards, NDCs and Mail-Order for GLP-1sA savings card is a second insurance claim, not a coupon. Here is the processing code your pharmacist actually needs, how to read the NDC to confirm you got the right dose and device, and how the two manufacturer mail-order channels work.Can You Fly With Ozempic? The TSA Rules, and What They Don't CoverTSA allows GLP-1 pens, needles and cooling packs through the checkpoint, with one requirement most travelers miss. Here is what TSA actually publishes, what the drug labels add, and where the rules stop helping.How to Dispose of GLP-1 Needles and Pens (and What Your State Allows)FDA's rule is two steps. Your state's rule is the one that decides what happens to the full container, and four states do not let it go in household trash at all. Here is the whole process, plus the free container programs most people do not know exist.How to Store GLP-1 Pens: The Full Table, Plus Travel and HeatThere are at least seven different out-of-fridge windows across the GLP-1 products sold in the US, ranging from 21 days to 56 days, and two products that never need a fridge at all. Here is every rule, from the labels, in one place.Missed a Dose of Ozempic, Wegovy, Mounjaro or Zepbound? What the Labels SayEvery GLP-1 has a different missed-dose rule, and two of them are written backward from each other. Here is what each FDA-approved label actually says, for nine drugs, in one table.
Results & daily life
Best and Worst Foods on GLP-1s, According to Dietitian GuidanceWhat registered dietitians and clinical-nutrition reviews say about which foods work and which cause trouble on semaglutide and tirzepatide — plus what the research actually shows about food aversions and taste changes.Daily Life on a GLP-1: Work, Travel, Tracking and the Stuff Nobody Warns You AboutThe practical side of living on semaglutide or tirzepatide: dose day and work, travel and storage rules from the labels, tracking apps and what the research says about them, non-scale victories, stigma at work, and the daily-life questions nobody has studied yet.Exercise on GLP-1s: What the Evidence Actually ShowsStrength training and cardio while taking semaglutide or tirzepatide: what randomized trials, meta-analyses and society guidance say about muscle, results, and what happens after the drug stops — plus an honest map of what has never been tested.Food Noise Explained: What It Is and What the Research Now ShowsFood noise went from a patient phrase to a measured research construct in under two years. Here is the formal definition, the two validated questionnaires, what the studies found about GLP-1 drugs and food noise, and where the science is still thin.How Much Protein on a GLP-1? What Dietitians and the Research SayProtein targets on semaglutide and tirzepatide, where the numbers come from, why per-kilogram advice is confusing, what the body-composition data actually shows, and why protein alone will not do the job.
Side effects & safety
Can You Drink Alcohol on Semaglutide?There is no alcohol warning on the semaglutide label, but there are three real reasons drinking feels different on this drug, and two randomized trials now show it changes how much people drink.Does Semaglutide Cause Muscle Loss?Some of the weight lost on semaglutide is lean tissue, which is true of nearly all weight loss, but the size of that share and what changes it are the parts worth understanding.How to Manage Nausea on Semaglutide: What the Research and Labels SayNausea hits nearly half the people who start semaglutide at the weight-management dose, and the label itself explains why the dose schedule exists and what to do when a step up does not go well.Ozempic Face: What It Is and Why It Happens"Ozempic face" is a nickname, not a diagnosis, for the hollowed look that can follow fast weight loss, and the published research says the drug is not attacking your skin.Ozempic Lawsuits: Gastroparesis, NAION and the MDL ExplainedThere are now two federal Ozempic litigations in Philadelphia, one for stomach injuries and one for sudden vision loss, and this explains what each one alleges, where it stands and what the science actually shows.Semaglutide and Surgery: The Anesthesia QuestionAnesthesiologists spent two years arguing about whether to stop GLP-1 drugs before surgery, and the guidance has now flipped once, so here is what the label, the societies and the trials actually say.Semaglutide Side Effects: The Complete List With How Common Each One IsA plain-English walkthrough of every semaglutide side effect that appears in the FDA labels for Ozempic, Wegovy and Rybelsus, with the actual trial percentages next to each one.Tirzepatide vs Semaglutide Side Effects: What the Head-to-Head Evidence ShowsA direct comparison of Zepbound and Mounjaro against Wegovy and Ozempic on side effects, using the one randomized head-to-head trial, the best observational study, and the differences written into the two labels.
Culture
Celebrities on Ozempic: A Sourced ListA documented list of public figures who have said on the record that they used a GLP-1 drug, with the exact drug where they named it, the date, and the quote - and a note on why speculation about everyone else does not belong here.How Many Americans Take GLP-1 Drugs: The NumbersGallup puts current GLP-1 use for weight loss at 11% of US adults and KFF puts current use for any reason at 12%, and this guide explains what those numbers count, how fast they grew, and who is actually taking the drugs.How Ozempic Changed American CultureIn four years a diabetes brand became American shorthand for thinness, rewrote how we talk about appetite and willpower, and reshaped everything from Oscar monologues to grocery aisles - here is what actually changed and what the evidence shows.Ozempic and Eating Disorders: The DebateGLP-1 drugs quiet appetite, which is exactly what makes clinicians who treat eating disorders uneasy - here is what the research actually shows, where experts disagree, and what the professional guidance says about screening.The GLP-1 Economy: Who Wins and LosesGLP-1 drugs are reshaping grocery baskets, restaurant menus, clothing sizes, gym memberships and airline fuel bills - here is what the spending data actually shows about which industries gain and which shrink.
Getting started
Do I Qualify for Wegovy, Zepbound or Another GLP-1?A plain-English walk through who each FDA-approved GLP-1 is actually labeled for, where the BMI 30 and BMI 27 rules come from, what counts as a weight-related condition, and why your insurance plan may use stricter rules than the FDA label.Questions to Ask Your Doctor About GLP-1 MedicationThirty-one questions worth asking before and after you start a GLP-1, each one tied to something a specific FDA label, guideline recommendation or federal rule actually says, plus what a good answer sounds like.What to Expect Your First Month on a GLP-1Week by week through the starting dose, why it is deliberately too low to be a treatment dose, the side effect rates recorded in trials, the missed-dose rules that differ by product, and what the labels say should prompt a call to your clinician.
Cost & insurance
Does Medicare Cover Wegovy or Ozempic?Medicare Part D can cover semaglutide for diabetes, heart disease and kidney disease, and since July 1, 2026 a temporary program called the Medicare GLP-1 Bridge covers Wegovy for obesity at a flat $50 a month through the end of 2027.How Much Does Semaglutide Cost Without Insurance in 2026?Without insurance, brand-name semaglutide now runs about $149 to $499 a month depending on which product and dose you take, far below the $1,027 to $1,349 list prices.Ozempic Savings Card and Coupons ExplainedThe Ozempic and Wegovy savings cards cut your copay to as little as $25 a month if you have commercial insurance that covers the drug, but they help with no more than $100 a month and are useless if you are uninsured or on Medicare.The Cheapest Way to Get Semaglutide Legally: Every Option ComparedEight legal routes to semaglutide in 2026, ranked by what you actually pay, from a $25 copay with good insurance down to the $149 pill and up to the $1,349 list price.When Will Generic Semaglutide Be Available?Generic semaglutide reached Canada, India and Brazil in 2026, but Novo Nordisk's US compound patent runs to about 2032, so Americans are unlikely to see an FDA-approved generic before the early 2030s.Why Do GLP-1s Cost Less in Other Countries?Americans have long paid several times what people in Japan, Germany or the UK pay for the same semaglutide, because other countries negotiate prices nationally and because US patents run years longer.
Medications
Every FDA-Approved GLP-1 Medication (2026 List)A complete, sourced list of every GLP-1 receptor agonist medication approved and sold in the United States as of September 2026, including what each one treats, what it costs and which ones have been discontinued.Every GLP-1 Drug Ranked by Effectiveness, Using Trial DataA ranking of the GLP-1 and incretin drugs approved in the US, built from published trial results rather than marketing claims — including which comparisons are direct head-to-head trials and which are educated guesses.How to Store and Use a Semaglutide Pen (From the Label)What the FDA-approved labels actually say about refrigerating, warming, injecting, disposing of and spotting counterfeit Ozempic and Wegovy pens.Imcivree Explained: The Obesity Drug That Is Not a GLP-1Imcivree (setmelanotide) treats rare forms of obesity caused by a broken hunger circuit in the brain, not common obesity. Here is who it is for, how it differs from Ozempic and Zepbound, what the trials showed, and what it costs.Ozempic vs Mounjaro: How the Two Diabetes Shots CompareOzempic and Mounjaro are both once-weekly injections for type 2 diabetes, but they are different molecules with different dosing ladders, different extra indications and different device options.Ozempic vs Wegovy vs Rybelsus: What's the Difference?Ozempic, Wegovy and Rybelsus all contain semaglutide, but they carry different FDA-approved uses, different doses and very different prices - and in 2026 Rybelsus was rebranded as the Ozempic pill.Switching GLP-1 Medications: What the Guidelines and Labels Actually SayThere is no FDA-approved conversion chart between different GLP-1 drugs. Here is what the labels do say about switching, what the published guidance recommends, and what happens when a discontinuation or a formulary change forces the decision for you.Trulicity vs Ozempic: What the Head-to-Head Trial Actually ShowedTrulicity and Ozempic are both once-weekly GLP-1 injections for type 2 diabetes, and they were compared directly in a 1,201-person trial. Here is what that trial found, how the two drugs differ on dosing, devices, price and heart benefits, and what is changing in 2026.
Pipeline
Every GLP-1 Drug in Development in 2026: The Full Pipeline, ExplainedA plain-English guide to the obesity and GLP-1 drugs now in development, which companies are behind them, how far along they are, and what each one is actually trying to do differently.When Will Generic Ozempic Be Available in the US?Generic semaglutide is already on sale in India and Canada, but the US patent situation pushes an American generic to the end of 2031 at the earliest. Here is the timeline and what is available in the meantime.
Foundayo
Specific groups
GLP-1 Drugs and Men's Health: Testosterone, Sex, Muscle and ResultsMen lose less percentage weight than women on the same dose, their testosterone tends to rise as they lose weight, the erectile function evidence points in two directions at once, and the muscle question is real. Here is what the 2025-2026 research actually found.GLP-1 Drugs for Teens: What Parents Should Know in 2026Two GLP-1 medicines are FDA-approved for adolescents with obesity, one is approved for children as young as 10 with type 2 diabetes, and none are approved under 12 for weight. Here is what the trials found, what the American Academy of Pediatrics guideline says, and what questions are still genuinely open.GLP-1s and Menopause: What the Research Actually ShowsMenopause changes where your body stores fat and how much energy you burn, and GLP-1 drugs work in perimenopausal and postmenopausal women about as well as they work in younger women. The newer and more interesting question is whether menopause hormone therapy makes them work even better - here is what the evidence says, and what it does not say.GLP-1s for Type 1 Diabetes: What the Research Shows in 2026No GLP-1 or dual incretin drug is approved for type 1 diabetes anywhere, and the Wegovy label says use in type 1 diabetes has not been evaluated. But a randomized trial, a Danish national cohort and UK real-world data now exist - and they say something more specific than 'off-label.'GLP-1s Over 65: What the Data Actually ShowsNo GLP-1 label sets an age limit or an age-based dose, and trial analyses in adults 65 and older find efficacy close to younger adults. The real differences are tolerability, muscle and function, one specific fracture observation in the Wegovy label, and the fact that Medicare will not pay for weight loss.Who Should Not Take GLP-1 Drugs, According to the LabelsThe FDA labels for Wegovy, Ozempic, Zepbound and Mounjaro list exactly two absolute contraindications each. Everything else - pancreatitis, gallbladder disease, gastroparesis, pregnancy, surgery, eye disease - sits in warnings, 'not recommended' statements, and gaps where nobody has studied the question at all. Here is the actual list.
How they work
How Does Mounjaro Work? The Science Behind Tirzepatide, in Plain EnglishMounjaro is tirzepatide, a once-weekly injection for type 2 diabetes that copies two gut hormones instead of one. Here is what it does to insulin, glucagon, your stomach and your appetite, straight from the FDA label and the research behind it.How Does Semaglutide Work? The Mechanism, Explained SimplySemaglutide is a lab-modified copy of a gut hormone that tells your pancreas to release insulin, tells your liver to hold back sugar, slows your stomach, and signals fullness to your brain - and the modifications let one dose last about a week.How Does Zepbound Work? GIP and GLP-1 ExplainedZepbound is tirzepatide, the same molecule as Mounjaro, approved for weight management and sleep apnea. It activates two gut hormone receptors - GIP and GLP-1 - and this guide explains what each one does to appetite, fat tissue and the brain.How Long Does Semaglutide Stay in Your System?The FDA label answers this directly: with a half-life of about one week, semaglutide stays in your circulation for roughly five weeks after your last dose - which shapes everything from side effects to surgery to pregnancy planning.Oral vs Injectable Semaglutide: What's the Difference in 2026?Same molecule, three US brand names across five presentations, two completely different journeys into the bloodstream - and a 2026 rebranding that means Ozempic now comes as both a pen and a pill that are not interchangeable.Semaglutide vs Tirzepatide: How the Two Drugs Actually DifferSemaglutide hits one receptor, tirzepatide hits two - and in the only head-to-head trial, tirzepatide produced more weight loss, though the two molecules differ in more ways than a single number captures.Tirzepatide and Birth Control: What the Label Actually SaysMounjaro and Zepbound are the only once-weekly GLP-1-family drugs whose US labels carry a specific oral contraceptive warning. Here is the exact wording, the study numbers behind it, and how it differs from semaglutide.What Is GLP-1? A Plain English Guide to the Hormone Behind OzempicGLP-1 is a hormone your intestines release after you eat that helps control blood sugar and tells your brain you have had enough - and the entire Ozempic and Wegovy class of drugs exists to copy it.Who Discovered GLP-1 Drugs? The Real History Behind OzempicThe story runs from a 1902 dog experiment to a Gila monster in Arizona to five scientists sharing the 2025 Breakthrough Prize - and no, Ozempic is not made from lizard venom.
Compounded & telehealth
How Online GLP-1 Prescriptions WorkA plain-English walkthrough of what happens between filling out an online weight loss questionnaire and a box arriving at your door, and the questions that decide whether the process is legitimate.How to Spot Counterfeit OzempicCounterfeit Ozempic pens have reached the legitimate U.S. supply chain three separate times, and the fastest way to check yours is where the EXP/LOT text sits on the pen label.
Companies
How Ozempic Changed DenmarkOne drug from one company reshaped the economy of a country of six million people — and when the boom cooled in 2025, Denmark felt that too.Novo Nordisk's Pipeline: What Comes After WegovyA plain-English guide to what Novo Nordisk is working on next — CagriSema, zenagamtide, cagrilintide, the oral pills already on the market, and the trials that failed along the way.Who Makes Ozempic? Novo Nordisk ExplainedOzempic, Wegovy and the Ozempic pill are all made by Novo Nordisk, a 100-year-old Danish company controlled by a charitable foundation — here is how it works, where the drugs are made, and how much money it brings in.
FDA & regulation
Is Compounded Semaglutide FDA Approved? The 2026 Rules ExplainedCompounded semaglutide is not FDA approved and never has been, and since the 2025 shortage delisting most routine compounding of Ozempic and Wegovy copies is no longer lawful.Is Semaglutide Still in Shortage? What the FDA List Says in 2026The FDA declared the semaglutide injection shortage resolved on February 21, 2025, and it has not returned since, which is why compounded copies of Ozempic and Wegovy are no longer generally legal.Semaglutide Approvals by Country: Where Ozempic and Wegovy Are ApprovedA country-by-country guide to semaglutide approvals, from the US and EU to Canada's first-in-the-G7 generics, plus where the Wegovy pill is available and where the labels disagree.The Complete FDA Approval History of Semaglutide (2017-2026)Every FDA approval, new indication and major label change for semaglutide from the first Ozempic approval in December 2017 through the Wegovy pill, Wegovy HD 7.2 mg and the Ozempic tablets rebrand in 2026.What the FDA Says About GLP-1 Safety: Every Warning on the LabelA plain-English tour of the FDA's official safety positions on semaglutide and the GLP-1 class, including the boxed warning, the anesthesia warning, the warning the FDA removed in 2026, and the one Europe added that the US has not.
Insurance navigation
Beyond weight loss
Microdosing Semaglutide: What's Actually KnownAbout one in seven GLP-1 users says they microdose, telehealth companies sell programs built around it, and there is not a single randomized trial showing it works.Ozempic Babies: Semaglutide, Fertility and PregnancyUnplanned pregnancies on GLP-1 drugs are real, the likely mechanism is restored ovulation from weight loss, and the pregnancy safety data as of 2026 are cautiously reassuring but still limited.Semaglutide and Alcohol Cravings: What the Research ShowsThree randomized trials have now tested semaglutide for drinking, and the results are more encouraging than most people expect, though no GLP-1 drug is approved for alcohol use disorder.Semaglutide and Alzheimer's: What the EVOKE Trials FoundTwo of the largest Alzheimer's trials ever run tested oral semaglutide in 3,808 people and found no slowing of the disease, closing a hypothesis that observational studies had made look promising.Semaglutide for PCOS: What the Evidence Actually ShowsSemaglutide is not approved for polycystic ovary syndrome anywhere, but a growing set of small trials suggests it helps with weight, insulin resistance and menstrual cycles in women who also carry excess weight.What Else Can Semaglutide Treat? Uses Beyond Weight LossA plain-English guide to everything semaglutide is FDA-approved to treat in 2026, what it is still being studied for, and which headline findings have not held up.
Clinical trials
Semaglutide vs Tirzepatide Head to Head: What SURMOUNT-5 FoundSURMOUNT-5 is the only large randomized trial that pitted tirzepatide directly against semaglutide at obesity doses — here are the numbers, the caveats, and what the trial could not measure.What Happens When You Stop Taking SemaglutideTrial data shows most people regain about two-thirds of lost weight within a year of stopping semaglutide, and blood pressure, cholesterol and blood sugar drift back toward baseline.
News
Semaglutide: A Year-by-Year HistoryA plain-English timeline of semaglutide from its 2017 approval as Ozempic through the Wegovy pill, the price collapse and the 2026 patent cliff.The Biggest GLP-1 Stories of 2025The ten developments that reshaped semaglutide and the wider GLP-1 market in 2025, from the end of the shortage to the first GLP-1 pill for weight loss.The Biggest GLP-1 Stories of 2026 So FarFrom the Wegovy pill launch to Medicare's $50 copay and the March patent cliff, the developments that have defined the GLP-1 market through September 2026.
Market & policy
State Medicaid and GLP-1s: Who Covers WhatOnly 13 state Medicaid programs covered GLP-1s for obesity as of January 2026, down from 16 the previous fall. Here is which states dropped coverage, why, what is still required by federal law, and what the CMS BALANCE model was supposed to change.The GLP-1 Patent Cliff: What Happens in 2031 and 2032Semaglutide's main US compound patent expires December 5, 2031, tirzepatide's January 5, 2036. Here is what that actually means for prices, which patents could delay generics, and why the rest of the world already has cheap semaglutide.Where GLP-1 Drugs Are Made in the USA state-by-state map of the US plants making semaglutide and tirzepatide, the tens of billions being spent to build more, the jobs those plants create, and why tariffs and drug pricing deals drove the whole build-out.
Liraglutide
Switching From Liraglutide to a Weekly GLP-1: What the Labels Actually SayThere is no official conversion chart from Saxenda or Victoza to Wegovy, Ozempic or Zepbound. Here is what the FDA labels do say about starting doses, overlapping GLP-1 drugs and shortages, plus the one study that tested a direct switch.Victoza vs Ozempic: The Daily and Weekly Diabetes Shots ComparedVictoza is daily liraglutide; Ozempic is weekly semaglutide. Both lower A1C and both cut cardiovascular risk in large outcome trials. The head-to-head data, the heart evidence, the price gap now that Victoza has generics, and what the labels actually say.
Stopping & switching
Switching From Ozempic to Mounjaro: What to KnowOzempic and Mounjaro are diabetes drugs, so a switch involves blood sugar as well as weight. Here is what the labels say, what the switching studies found, and what changes about monitoring in the first three months.What Happens When You Stop Taking a GLP-1: The EvidenceRandomized trials, real-world databases and meta-analyses now give a fairly clear picture of what happens to weight, blood sugar, blood pressure and body composition after a GLP-1 stops - and where the numbers disagree.
Recent Ozempic news
Full timeline- Prices
Status check: Novo Nordisk's $675 list price still lands well above every negotiated and cash price
- Prices
Novo Nordisk aligns Ozempic pricing with generics in Canada as Apotex begins shipping
- Safety
Health Canada warns on counterfeit and unauthorized Ozempic and Mounjaro sellers
- Research
New analysis finds semaglutide and tirzepatide produce similar weight loss in type 2 diabetes
- Safety
Case report: a pen-handling error delivered four weekly semaglutide doses at once
- Policy
Medicare's second negotiation round trims 15 drugs including Ozempic, saving about $685 million
- Prices
Hims & Hers opens a waitlist for $149 Wegovy and Ozempic under the Novo deal
- Compounding
Novo Nordisk wins a false-advertising ruling against an Ozempic copycat pharmacy